Are statins as risky as labels suggest? 📊

In a 154,664-patient individual-participant meta-analysis of 23 double-blind RCTs, only 4 of 66 listed adverse effects were confirmed — mainly small, dose-related liver enzyme elevations.

No causal signal for cognitive decline, depression, sleep disturbance, neuropathy, or kidney injury.

Absolute excess risks were tiny (

Cardiovascular benefit still overwhelmingly outweighs risk. Evidence matters. 💡